Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
- PMID: 31123293
- PMCID: PMC6533364
- DOI: 10.1038/s41598-019-44245-9
Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
Abstract
A 12-lead ECG is a simple and less costly measure to assess cardiac amyloidosis and may reflect the infiltrative nature of cardiac amyloidosis and have prognostic value for predicting overall survival in patients with cardiac AL amyloidosis. Therefore, we investigated the associations of surface ECG parameters with left ventricular (LV) global longitudinal strain (GLS) and prognosis in patients with cardiac AL amyloidosis. We performed a multi-center, retrospective analysis of 102 biopsy-proven cardiac AL amyloidosis patients. Baseline studies included 12-lead surface ECG and echocardiography, with two-dimensional strain analysis performed within one month of diagnosis. From the Kaplan-Meier survival analysis, patients with prolonged QTc (≥483 msec) had significantly poorer survival. ECG scores were assigned according to presence of prolonged QTc (≥483 msec) and abnormal QRS axis, and the study participants were divided into three groups according to ECG score. Mean absolute value of LV GLS and regional LV longitudinal strain (LS) differed significantly among the three groups and decreased in a stepwise manner as ECG score increased. Log NT-proBNP increased in a stepwise manner as ECG score increased. Prolonged QTc (≥483 msec) and abnormal QRS axis showed significant incremental values in addition to the revised Mayo stage. The presence of prolonged QTc (≥483 msec) and abnormal QRS axis showed significant incremental values for overall mortality rates. In addition, ECG scores consisting of presence of prolonged QTc (≥483 msec), and abnormal QRS axis showed good association with longitudinal LV dysfunction and NT-proBNP. ECG finding may provide prognostic additional information regarding prognosis of AL amyloidosis with cardiac involvement.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.Int J Cardiovasc Imaging. 2019 May;35(5):845-854. doi: 10.1007/s10554-018-01524-2. Epub 2019 Jan 8. Int J Cardiovasc Imaging. 2019. PMID: 30623354
-
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.J Am Soc Echocardiogr. 2018 Jan;31(1):64-70. doi: 10.1016/j.echo.2017.08.017. Epub 2017 Oct 27. J Am Soc Echocardiogr. 2018. PMID: 29111123 Free PMC article.
-
Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.BMC Cardiovasc Disord. 2021 Jan 21;21(1):43. doi: 10.1186/s12872-021-01856-3. BMC Cardiovasc Disord. 2021. PMID: 33478398 Free PMC article.
-
Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.Curr Probl Cardiol. 2024 Sep;49(9):102729. doi: 10.1016/j.cpcardiol.2024.102729. Epub 2024 Jun 29. Curr Probl Cardiol. 2024. PMID: 38945183 Review.
-
Cardiac amyloidosis: updates in diagnosis and management.Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23. Arch Cardiovasc Dis. 2013. PMID: 24070600 Review.
Cited by
-
Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging.Front Cardiovasc Med. 2021 Dec 6;8:751422. doi: 10.3389/fcvm.2021.751422. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34938781 Free PMC article.
-
Bad players in AL amyloidosis in the current era of treatment.Expert Rev Hematol. 2023 Jan;16(1):33-49. doi: 10.1080/17474086.2023.2166924. Epub 2023 Jan 12. Expert Rev Hematol. 2023. PMID: 36620914 Free PMC article.
-
Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication.Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):27-35. doi: 10.14797/mdcvj.1070. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35414848 Free PMC article. Review.
-
Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis.ESC Heart Fail. 2021 Dec;8(6):5594-5599. doi: 10.1002/ehf2.13604. Epub 2021 Sep 16. ESC Heart Fail. 2021. PMID: 34528755 Free PMC article.
-
Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma.J Clin Med. 2023 Mar 30;12(7):2595. doi: 10.3390/jcm12072595. J Clin Med. 2023. PMID: 37048679 Free PMC article.
References
-
- Bellavia D, et al. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2010;23:643–652. doi: 10.1016/j.echo.2010.03.027. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous